Activated MAPK signaling pathways contribute to the pathogenesis of AD through various mechanisms, including induction of neuronal apoptosis [29,30], transcriptional and enzymatic activation of β- and γ-secretases [31], and phosphorylation and stabilization of the β-amyloid precursor (APP) [32,33]. The gene discussed is APP; the disease is Alzheimer disease.